Scott A Tomlins Selected Research

ErbB Receptors (EGF Receptor)

4/2015	Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.
2/2006	Enhancing the antitumor activity of ErbB blockade with histone deacetylase (HDAC) inhibition.
4/2005	Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Scott A Tomlins Research Topics

Disease

111	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 09/2003
104	Neoplasms (Cancer) 04/2024 - 06/2004
14	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2007
13	Adenoma (Adenomas) 11/2020 - 08/2015
12	Carcinoma (Carcinomatosis) 01/2021 - 08/2009
9	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2003
9	Hyperaldosteronism (Conn Syndrome) 11/2020 - 01/2017
9	Adenocarcinoma 12/2019 - 02/2005
8	Carcinogenesis 01/2018 - 11/2006
7	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019 - 05/2009
6	Disease Progression 01/2022 - 05/2009
5	Circulating Neoplastic Cells 01/2022 - 09/2016
4	Retinoblastoma (Glioblastoma, Retinal) 01/2022 - 02/2012
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 11/2016
3	Leiomyomatosis 01/2018 - 11/2016
3	Lymphatic Metastasis 01/2018 - 09/2006
3	Lymphoma (Lymphomas) 01/2017 - 06/2013
3	Fibrosis (Cirrhosis) 11/2016 - 04/2004
3	Prostatic Intraepithelial Neoplasia 08/2012 - 02/2008
2	Squamous Cell Carcinoma of Head and Neck 02/2024 - 01/2016
2	Lung Neoplasms (Lung Cancer) 02/2023 - 07/2010
2	Merkel Cell Carcinoma 01/2021 - 03/2016
2	Adrenocortical Adenoma (Disease, Conn's) 01/2020 - 03/2016
2	Endometrioid Carcinoma 01/2020 - 11/2015
2	Hyperplasia 10/2018 - 01/2017
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2018 - 12/2015
2	Hypertension (High Blood Pressure) 07/2017 - 01/2017
2	Sarcoma (Soft Tissue Sarcoma) 12/2016 - 07/2010
2	Margins of Excision 11/2016 - 01/2015
2	Inflammation (Inflammations) 07/2015 - 04/2004
2	familial Prostate cancer 06/2014 - 05/2014
2	Leukemia 06/2013 - 07/2010
2	Hypoxia (Hypoxemia) 11/2012 - 02/2006
1	Wounds and Injuries (Trauma) 04/2023
1	Microsatellite Instability 02/2023
1	Gynecomastia 01/2022

Drug/Important Bio-Agent (IBA)

29	AndrogensIBA 01/2021 - 06/2004
26	Biomarkers (Surrogate Marker)IBA 04/2024 - 11/2006
25	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2003
20	Prostate-Specific Antigen (Semenogelase)IBA 04/2024 - 11/2006
20	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 09/2006
18	RNA (Ribonucleic Acid)IBA 04/2024 - 02/2006
15	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 05/2010
15	AldosteroneIBA 11/2020 - 08/2015
12	Proto-Oncogene Proteins c-etsIBA 02/2015 - 10/2005
11	Formaldehyde (Formol)FDA Link 11/2021 - 03/2015
11	ParaffinIBA 11/2021 - 03/2015
11	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 08/2020 - 08/2015
11	Kazal Pancreatic Trypsin InhibitorIBA 12/2019 - 02/2008
9	Messenger RNA (mRNA)IBA 01/2020 - 03/2004
9	Transcription Factors (Transcription Factor)IBA 10/2016 - 09/2007
7	AntigensIBA 01/2021 - 08/2011
6	Hormones (Hormone)IBA 01/2021 - 06/2004
6	ChromatinIBA 01/2019 - 07/2010
5	Serine Proteases (Serine Protease)IBA 11/2015 - 08/2008
4	enzalutamideIBA 01/2022 - 01/2019
4	Fumarate Hydratase (Fumarase)IBA 01/2019 - 11/2016
4	Phenobarbital (Luminal)FDA Link 01/2019 - 12/2017
4	5' Untranslated Regions (5' UTR)IBA 11/2009 - 10/2005
4	Complementary DNA (cDNA)IBA 02/2006 - 04/2004
3	Immune Checkpoint InhibitorsIBA 02/2023 - 06/2018
3	Estrogen ReceptorsIBA 01/2022 - 06/2009
3	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2020 - 08/2016
3	Cell-Free Nucleic AcidsIBA 01/2020 - 09/2016
3	Testosterone (Sustanon)FDA Link 01/2019 - 10/2012
3	Phosphotransferases (Kinase)IBA 01/2019 - 06/2013
3	ErbB Receptors (EGF Receptor)IBA 04/2015 - 04/2005
3	ElementsIBA 11/2012 - 04/2004
2	Circulating Tumor DNAIBA 02/2024 - 01/2022
2	Histones (Histone)IBA 01/2020 - 07/2012
2	B7-H1 AntigenIBA 01/2020 - 10/2018
2	abirateroneIBA 01/2020 - 01/2019
2	Small Interfering RNA (siRNA)IBA 01/2019 - 11/2012
2	bicalutamide (Casodex)FDA LinkGeneric 01/2019 - 10/2012
2	Docetaxel (Taxotere)FDA Link 01/2019 - 01/2016
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2018 - 06/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2017 - 09/2004
2	ReninIBA 01/2017 - 08/2015
2	EnzymesIBA 01/2017 - 03/2004
2	MicroRNAs (MicroRNA)IBA 12/2015 - 08/2011
2	Membrane Proteins (Integral Membrane Proteins)IBA 11/2012 - 11/2008
2	Tissue ExtractsIBA 11/2005 - 03/2004
2	Tyrosine Kinase InhibitorsIBA 04/2005 - 09/2004
2	alpha-methylacyl-CoA racemaseIBA 09/2004 - 03/2004
1	ZincIBA 04/2023
1	VenomsIBA 04/2023
1	pembrolizumabIBA 02/2023
1	Androgen Antagonists (Antiandrogens)IBA 01/2023
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022

Therapy/Procedure

34	Therapeutics 02/2023 - 05/2007
24	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 10/2006
18	Castration 01/2022 - 02/2012
10	Precision Medicine 01/2023 - 05/2015
4	Immunotherapy 02/2023 - 01/2019
4	Drug Therapy (Chemotherapy) 01/2023 - 09/2004
3	Lasers (Laser) 09/2007 - 01/2007
2	Adrenalectomy 11/2020 - 10/2018
2	Radiotherapy 01/2019 - 11/2016
2	Lymph Node Excision (Lymph Node Dissection) 01/2018 - 08/2017